Visit SOFIE at booth 1116 at the upcoming Annual SNMMI Meeting from June 8 – June 11, 2024 in Toronto, CA.
Don’t miss the satellite symposia co-sponsored by SOFIE and GE Healthcare on
Sunday, June 9, 2024 from 6:30–8:30 pm (South Building, 700 Level, Room 718A)
Title: Driving Molecular Imaging Innovation with “FAPI”*
FAP (fibroblast activation protein) as a diagnostic and therapeutic target for radiopharmaceuticals has seen many advances in recent years. This special session will bring together researchers and industry to discuss the latest progress in this space and current research applications.
Speakers:
- Current state of FAP imaging: technology vs research applications
Andrew Scott – Olivia Newton-John Cancer Research Institute (Australia) - Perspectives on FAPI* Phase II progress
Shadi Esfahani – Massachusetts General Hospital (US) - The pivotal role of Fibroblasts in Inflammation and Fibrosis
Olivier Gheysens – Cliniques Universitaires Saint-Luc UCLouvain (Belgium)
Panel Discussion:
Fibroblast-targeting therapeutic strategies in Cancer, Inflammation and Fibrotic diseases
Panel/Moderator: Andrew Scott
Josie Gayton (Precirix)
Philippe Legenne (Molecular Partners)
Stephen Moran (Novartis)
*Represent concepts in development that are not yet products and may never become products. None of these concepts are being offered for sale today or have been cleared or approved by any regulatory authority for commercial availability.